Integra Lifesciences Holdings (IART) Other Non Operating Income (2009 - 2026)

Integra Lifesciences Holdings has disclosed Other Non Operating Income across 18 years of filings, most recently posting $4.2 million for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 315.11% year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $8.4 million (up 718.4% YoY), while the FY2025 annual figure was -$2.4 million, down 159.61% from the prior year.
• Other Non Operating Income came in at $4.2 million for Q2 2026 at Integra Lifesciences Holdings, down from $4.5 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $4.5 million in Q1 2026 to a low of -$1.9 million in Q2 2025.
• Average Other Non Operating Income over 5 years is $1.4 million, with a median of $1.4 million recorded in 2023.
• Year-over-year, Other Non Operating Income slumped 235.42% in 2025 and jumped 3211.11% in 2026.
• Over 5 years, Other Non Operating Income stood at $4.0 million in 2022, then tumbled by 49.05% to $2.0 million in 2023, then slumped by 50.07% to $1.0 million in 2024, then plunged by 42.19% to $581000.0 in 2025, then soared by 620.48% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $4.2 million in Q2 2026, $4.5 million in Q1 2026, and $581000.0 in Q4 2025.